ProCE Banner Activity

Assessing the Options for Patients With Renal Cell Carcinoma

Clinical Thought

Cristina Salabao, MSN, FNP-C, AOCNP provides key updates on the use of available regimens in renal cell carcinoma (RCC) across the adjuvant, first-line, and second-line settings.

Released: August 22, 2022

Expiration: August 21, 2023

No longer available for credit.



Cristina Salabao

Cristina Salabao, MSN, FNP-C, AOCNP

Nurse Practitioner
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts


This program is supported by educational grants from Merck Sharp & Dohme Corp; Regeneron Pharmaceuticals, Inc. and Sanofi; and Taiho Oncology, Inc.

Provided by

ProCE Banner

Target Audience

Oncology NPs, PAs, and RNs


Cristina Salabao, MSN, FNP-C, AOCNP, has no relevant financial relationships to disclose.



Additional Information

Program Medium

This program has been made available online.